NCT07361705 2026-01-23Zorifertinib With Osimertinib for NSCLC With Meningeal ProgressionAlpha Biopharma (Jiangsu) Co., Ltd.Phase 1 Not yet recruiting42 enrolled
NCT07348965 2026-01-16Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal MetastasisGuangzhou University of Traditional Chinese MedicinePhase NA Not yet recruiting42 enrolled